Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Vancouver
- Most recent report
- 6-K, filed Oct 22, 2026
- Incorporated
- N/A
- Filings on record
- 126 filings
- On EDGAR
- CIK 1581178
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 91
- 6-K Report a foreign issuer made public elsewhere Oct 22, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 15, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 9, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 30, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 8, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 13, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 11, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 15, 2026
Prospectuses and Registrations 2
Ownership 8 of 10
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 13, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 12, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Mar 16, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Feb 17, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 14, 2025
- SCHEDULE 13G Large holder reported a passive stake Nov 14, 2025
- SCHEDULE 13G Large holder reported a passive stake Nov 13, 2025
- SCHEDULE 13D/A Large holder reported an active stake, amended Sep 26, 2025
Other 8 of 23
Everything here comes from Eupraxia Pharmaceuticals Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.